Prahlad R. Singh Sells 21,217 Shares of Revvity, Inc. (NYSE:RVTY) Stock

Revvity, Inc. (NYSE:RVTYGet Free Report) insider Prahlad R. Singh sold 21,217 shares of the company’s stock in a transaction that occurred on Monday, February 5th. The stock was sold at an average price of $104.28, for a total value of $2,212,508.76. Following the sale, the insider now directly owns 92,801 shares of the company’s stock, valued at approximately $9,677,288.28. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Revvity Stock Performance

Shares of RVTY opened at $103.29 on Friday. The business’s fifty day simple moving average is $104.54 and its two-hundred day simple moving average is $105.73. The company has a market cap of $12.75 billion, a price-to-earnings ratio of 18.78, a P/E/G ratio of 2.72 and a beta of 1.11. The company has a current ratio of 2.07, a quick ratio of 1.77 and a debt-to-equity ratio of 0.40. Revvity, Inc. has a 12 month low of $79.50 and a 12 month high of $144.50.

Revvity (NYSE:RVTYGet Free Report) last issued its quarterly earnings data on Thursday, February 1st. The company reported $1.25 earnings per share for the quarter, beating analysts’ consensus estimates of $1.15 by $0.10. The firm had revenue of $695.90 million during the quarter. Revvity had a return on equity of 7.41% and a net margin of 25.20%. Research analysts anticipate that Revvity, Inc. will post 4.64 earnings per share for the current fiscal year.

Revvity Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 10th. Stockholders of record on Friday, April 19th will be issued a dividend of $0.07 per share. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.27%. The ex-dividend date is Thursday, April 18th. Revvity’s dividend payout ratio (DPR) is presently 5.09%.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Parkside Financial Bank & Trust purchased a new stake in Revvity during the 4th quarter valued at about $25,000. Gladius Capital Management LP lifted its position in shares of Revvity by 84.1% during the 3rd quarter. Gladius Capital Management LP now owns 232 shares of the company’s stock worth $26,000 after purchasing an additional 106 shares during the last quarter. CENTRAL TRUST Co purchased a new stake in shares of Revvity during the 4th quarter worth $27,000. Benjamin F. Edwards & Company Inc. purchased a new stake in shares of Revvity during the 4th quarter worth $27,000. Finally, ORG Partners LLC purchased a new stake in Revvity in the fourth quarter valued at $32,000. 82.63% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several analysts have recently commented on RVTY shares. Evercore ISI upgraded Revvity from an “in-line” rating to an “outperform” rating and increased their target price for the stock from $88.00 to $125.00 in a report on Thursday, January 4th. KeyCorp raised their price target on Revvity from $110.00 to $126.00 and gave the stock an “overweight” rating in a research report on Friday, February 2nd. UBS Group lowered Revvity from a “buy” rating to a “neutral” rating and lifted their target price for the company from $105.00 to $125.00 in a research report on Tuesday, January 16th. Barclays raised their price target on Revvity from $92.00 to $105.00 and gave the company an “equal weight” rating in a research note on Thursday, January 25th. Finally, Stifel Nicolaus lifted their target price on Revvity from $95.00 to $110.00 and gave the stock a “hold” rating in a research note on Friday, February 2nd. Six investment analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $118.91.

Read Our Latest Stock Report on Revvity

About Revvity

(Get Free Report)

Revvity, Inc provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection, and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market, as well as contract research and laboratory services.

Featured Articles

Receive News & Ratings for Revvity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Revvity and related companies with MarketBeat.com's FREE daily email newsletter.